{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:04:07Z","timestamp":1761102247625,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T00:00:00Z","timestamp":1483920000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s11547-016-0718-2","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T05:41:06Z","timestamp":1483940466000},"page":"265-272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["1H- and 31P-myocardial magnetic resonance spectroscopy in non-obstructive hypertrophic cardiomyopathy patients and competitive athletes"],"prefix":"10.1007","volume":"122","author":[{"given":"Francesco","family":"Secchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Di Leo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Petrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Spairani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8156-7743","authenticated-orcid":false,"given":"Marco","family":"Al\u00ec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Guazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Sardanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,9]]},"reference":[{"key":"718_CR1","first-page":"107","volume":"8","author":"P Charron","year":"1997","unstructured":"Charron P, Carrier L, Dubourg O et al (1997) Penetrance of familial hypertrophic cardiomyopathy. Genet Couns 8:107\u2013114","journal-title":"Genet Couns"},{"key":"718_CR2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","volume":"92","author":"BJ Maron","year":"1995","unstructured":"Maron BJ, Gardin JM, Flack JM et al (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92:785\u2013789","journal-title":"Circulation"},{"key":"718_CR3","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0735-1097(02)03009-7","volume":"41","author":"JG Crilley","year":"2003","unstructured":"Crilley JG, Boehm EA, Blair E et al (2003) Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol 41:1776\u20131782","journal-title":"J Am Coll Cardiol"},{"key":"718_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0025-6196(11)63196-0","volume":"80","author":"SL Driest Van","year":"2005","unstructured":"Van Driest SL, Ommen SR, Tajik AJ et al (2005) Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc 80:463\u2013469. doi: 10.1016\/S0025-6196(11)63196-0","journal-title":"Mayo Clin Proc"},{"key":"718_CR5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/heart.86.6.709","volume":"86","author":"ED Wigle","year":"2001","unstructured":"Wigle ED (2001) Cardiomyopathy: the diagnosis of hypertrophic cardiomyopathy. Heart 86:709\u2013714","journal-title":"Heart"},{"key":"718_CR6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00392-008-0721-2","volume":"98","author":"J Lauschke","year":"2009","unstructured":"Lauschke J, Maisch B (2009) Athlete\u2019s heart or hypertrophic cardiomyopathy? Clin Res Cardiol 98:80\u201388","journal-title":"Clin Res Cardiol"},{"key":"718_CR7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/hrt.2008.142562","volume":"95","author":"A Esposito","year":"2009","unstructured":"Esposito A, De Cobelli F, Perseghin G et al (2009) Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging. Heart 95:228\u2013233","journal-title":"Heart"},{"key":"718_CR8","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","volume":"114","author":"MS Maron","year":"2006","unstructured":"Maron MS, Olivotto I, Zenovich AG et al (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114:2232\u20132239","journal-title":"Circulation"},{"key":"718_CR9","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/archinte.1995.00430140021002","volume":"155","author":"JN Wight","year":"1995","unstructured":"Wight JN, Salem D (1995) Sudden cardiac death and the \u201cathlete\u2019s heart\u201d. Arch Intern Med 155:1473\u20131480","journal-title":"Arch Intern Med"},{"key":"718_CR10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/heart.89.7.710","volume":"89","author":"S Firoozi","year":"2003","unstructured":"Firoozi S, Sharma S, McKenna WJ (2003) Risk of competitive sport in young athletes with heart disease. Heart 89:710\u2013714","journal-title":"Heart"},{"key":"718_CR11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM199101313240504","volume":"324","author":"A Pelliccia","year":"1991","unstructured":"Pelliccia A, Maron BJ, Spataro A et al (1991) The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 324:295\u2013301","journal-title":"N Engl J Med"},{"key":"718_CR12","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1161\/01.CIR.91.5.1596","volume":"91","author":"BJ Maron","year":"1995","unstructured":"Maron BJ, Pelliccia A, Spirito P (1995) Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete\u2019s heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 91:1596\u20131601","journal-title":"Circulation"},{"key":"718_CR13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2214\/AJR.08.1201","volume":"192","author":"F Cobelli De","year":"2009","unstructured":"De Cobelli F, Esposito A, Belloni E et al (2009) Delayed-enhanced cardiac MRI for differentiation of Fabry\u2019s disease from symmetric hypertrophic cardiomyopathy. AJR Am J Roentgenol 192:97\u2013102","journal-title":"AJR Am J Roentgenol"},{"key":"718_CR14","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s11547-006-0102-8","volume":"111","author":"F Sardanelli","year":"2006","unstructured":"Sardanelli F, Quarenghi M (2006) MR spectroscopy of the heart. Radiol Med 111:1025\u20131034","journal-title":"Radiol Med"},{"key":"718_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.pcad.2011.08.002","volume":"54","author":"CJ Holloway","year":"2011","unstructured":"Holloway CJ, Suttie J, Dass S, Neubauer S (2011) Clinical cardiac magnetic resonance spectroscopy. Prog Cardiovasc Dis 54:320\u2013327. doi: 10.1016\/j.pcad.2011.08.002","journal-title":"Prog Cardiovasc Dis"},{"key":"718_CR16","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/oxfordjournals.eurheartj.a015032","volume":"17","author":"HP Beyerbacht","year":"1996","unstructured":"Beyerbacht HP, Vliegen HW, Lamb HJ et al (1996) Phosphorus magnetic resonance spectroscopy of the human heart: current status and clinical implications. Eur Heart J 17:1158\u20131166","journal-title":"Eur Heart J"},{"key":"718_CR17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbabio.2004.05.003","volume":"1657","author":"R Lodi","year":"2004","unstructured":"Lodi R, Rajagopalan B, Blamire AM et al (2004) Abnormal cardiac energetics in patients carrying the A3243G mtDNA mutation measured in vivo using phosphorus MR spectroscopy. Biochim Biophys Acta 1657:146\u2013150","journal-title":"Biochim Biophys Acta"},{"key":"718_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/nbm.3320","volume":"28","author":"PA Ewijk van","year":"2015","unstructured":"van Ewijk PA, Schrauwen-Hinderling VB, Bekkers SCAM et al (2015) MRS: a noninvasive window into cardiac metabolism. NMR Biomed 28:747\u2013766. doi: 10.1002\/nbm.3320","journal-title":"NMR Biomed"},{"key":"718_CR19","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0140-6736(97)06402-7","volume":"351","author":"PA Bottomley","year":"1998","unstructured":"Bottomley PA, Weiss RG (1998) Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium. Lancet 351:714\u2013718","journal-title":"Lancet"},{"key":"718_CR20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10741-012-9341-z","volume":"18","author":"KME Faller","year":"2013","unstructured":"Faller KME, Lygate CA, Neubauer S, Schneider JE (2013) 1H-MR spectroscopy for analysis of cardiac lipid and creatine metabolism. Heart Fail Rev 18:657\u2013668","journal-title":"Heart Fail Rev"},{"key":"718_CR21","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2003.05.005","volume":"42","author":"I Nakae","year":"2003","unstructured":"Nakae I, Mitsunami K, Omura T et al (2003) Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol 42:1587\u20131593","journal-title":"J Am Coll Cardiol"},{"key":"718_CR22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/cvr\/cvn301","volume":"81","author":"JS Ingwall","year":"2009","unstructured":"Ingwall JS (2009) Energy metabolism in heart failure and remodelling. Cardiovasc Res 81:412\u2013419","journal-title":"Cardiovasc Res"},{"key":"718_CR23","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.amjcard.2010.01.368","volume":"105","author":"AE Malavazos","year":"2010","unstructured":"Malavazos AE, Di Leo G, Secchi F et al (2010) Relation of echocardiographic epicardial fat thickness and myocardial fat. Am J Cardiol 105:1831\u20131835. doi: 10.1016\/j.amjcard.2010.01.368","journal-title":"Am J Cardiol"},{"key":"718_CR24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1148\/radiol.2451061904","volume":"245","author":"RW Meer van der","year":"2007","unstructured":"van der Meer RW, Doornbos J, Kozerke S et al (2007) Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology 245:251\u2013257. doi: 10.1148\/radiol.2451061904","journal-title":"Radiology"},{"key":"718_CR25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF02668096","volume":"12","author":"A Naressi","year":"2001","unstructured":"Naressi A, Couturier C, Devos JM et al (2001) Java-based graphical user interface for the MRUI quantitation package. MAGMA 12:141\u2013152","journal-title":"MAGMA"},{"key":"718_CR26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/mrm.1910320205","volume":"32","author":"JA Hollander den","year":"1994","unstructured":"den Hollander JA, Evanochko WT, Pohost GM (1994) Observation of cardiac lipids in humans by localized 1H magnetic resonance spectroscopic imaging. Magn Reson Med 32:175\u2013180","journal-title":"Magn Reson Med"},{"key":"718_CR27","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/(SICI)1522-2594(199911)42:5<903::AID-MRM10>3.0.CO;2-N","volume":"42","author":"J Felblinger","year":"1999","unstructured":"Felblinger J, Jung B, Slotboom J et al (1999) Methods and reproducibility of cardiac\/respiratory double-triggered (1)H-MR spectroscopy of the human heart. Magn Reson Med 42:903\u2013910","journal-title":"Magn Reson Med"},{"key":"718_CR28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00330-004-2504-0","volume":"15","author":"A Hansch","year":"2005","unstructured":"Hansch A, Rzanny R, Heyne J-P et al (2005) Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging. Eur Radiol 15:319\u2013323","journal-title":"Eur Radiol"},{"key":"718_CR29","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1161\/01.CIR.97.25.2536","volume":"97","author":"WI Jung","year":"1998","unstructured":"Jung WI, Sieverding L, Breuer J et al (1998) 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 97:2536\u20132542","journal-title":"Circulation"},{"key":"718_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/978-88-470-1133-5","author":"F Sardanelli","year":"2009","unstructured":"Sardanelli F, Di Leo G (2009) Biostatistics for radiologists: planning, performing, and writing a radiologic study. Biostat Radiol Plan Perform Writ Radiol Study. doi: 10.1007\/978-88-470-1133-5","journal-title":"Biostat Radiol Plan Perform Writ Radiol Study"},{"key":"718_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2169\/internalmedicine.54.3024","volume":"54","author":"E Sai","year":"2015","unstructured":"Sai E, Shimada K, Yokoyama T et al (2015) Evaluation of myocardial triglyceride accumulation assessed on 1H-magnetic resonance spectroscopy in apparently healthy Japanese subjects. Intern Med 54:367\u2013373. doi: 10.2169\/internalmedicine.54.3024","journal-title":"Intern Med"},{"key":"718_CR32","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(04)16358-7","volume":"363","author":"P Elliott","year":"2004","unstructured":"Elliott P, McKenna WJ (2004) Hypertrophic cardiomyopathy. Lancet 363:1881\u20131891. doi: 10.1016\/S0140-6736(04)16358-7","journal-title":"Lancet"},{"key":"718_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0140-6736(12)60397-3","volume":"350","author":"BJ Maron","year":"1997","unstructured":"Maron BJ, Maron MS (1997) Hypertrophic cardiomyopathy. Lancet 350:127\u2013133. doi: 10.1016\/S0140-6736(12)60397-3","journal-title":"Lancet"},{"key":"718_CR34","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.amjcard.2013.05.036","volume":"112","author":"MD Nelson","year":"2013","unstructured":"Nelson MD, Victor RG, Szczepaniak EW et al (2013) Cardiac steatosis and left ventricular hypertrophy in patients with generalized lipodystrophy as determined by magnetic resonance spectroscopy and imaging. Am J Cardiol 112:1019\u20131024. doi: 10.1016\/j.amjcard.2013.05.036","journal-title":"Am J Cardiol"},{"key":"718_CR35","doi-asserted-by":"crossref","unstructured":"Utz W, Engeli S, Haufe S, Kast P, Hermsdorf M, Wiesner S, Pofahl M, Traber J, Luft FC, Boschmann M, Schulz-Menger J, Jordan J (2011) Myocardial steatosis, cardiac remodelling and fitness in insulin-sensitive and insulin-resistant obesewomen. Heart 97(19):1585\u20131589","DOI":"10.1136\/hrt.2011.224451"},{"key":"718_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1475-2840-10-47","volume":"10","author":"VB Schrauwen-Hinderling","year":"2011","unstructured":"Schrauwen-Hinderling VB, Meex RCR, Hesselink MKC et al (2011) Cardiac lipid content is unresponsive to a physical activity training intervention in type 2 diabetic patients, despite improved ejection fraction. Cardiovasc Diabetol 10:47. doi: 10.1186\/1475-2840-10-47","journal-title":"Cardiovasc Diabetol"},{"key":"718_CR37","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1148\/radiol.13121631","volume":"269","author":"JT Jonker","year":"2013","unstructured":"Jonker JT, de Mol P, de Vries ST et al (2013) Exercise and type 2 diabetes mellitus: changes in tissue-specific fat distribution and cardiac function. Radiology 269:434\u2013442. doi: 10.1148\/radiol.13121631","journal-title":"Radiology"},{"key":"718_CR38","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/01.CIR.97.7.666","volume":"97","author":"BM Pluim","year":"1998","unstructured":"Pluim BM, Lamb HJ, Kayser HW et al (1998) Functional and metabolic evaluation of the athlete\u2019s heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy. Circulation 97:666\u2013672","journal-title":"Circulation"},{"key":"718_CR39","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1055\/s-2004-813220","volume":"176","author":"M Gutberlet","year":"2004","unstructured":"Gutberlet M, Spors B, Grothoff M et al (2004) Comparison of different cardiac MRI sequences at 1.5 T\/3.0 T with respect to signal-to-noise and contrast-to-noise ratios\u2014initial experience. Rofo 176:801\u2013808. doi: 10.1055\/s-2004-813220","journal-title":"Rofo"},{"key":"718_CR40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1148\/radiology.219.2.r01ma39411","volume":"219","author":"PA Bottomley","year":"2001","unstructured":"Bottomley PA, Weiss RG (2001) Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium. Radiology 219:411\u2013418. doi: 10.1148\/radiology.219.2.r01ma39411","journal-title":"Radiology"},{"key":"718_CR41","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.2214\/AJR.07.3521","volume":"192","author":"F Sardanelli","year":"2009","unstructured":"Sardanelli F, Fausto A, Di Leo G et al (2009) In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy. Am J Roentgenol 192:1608\u20131617. doi: 10.2214\/AJR.07.3521","journal-title":"Am J Roentgenol"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-016-0718-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11547-016-0718-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-016-0718-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T03:38:44Z","timestamp":1498361924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11547-016-0718-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,9]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["718"],"URL":"https:\/\/doi.org\/10.1007\/s11547-016-0718-2","relation":{},"ISSN":["0033-8362","1826-6983"],"issn-type":[{"type":"print","value":"0033-8362"},{"type":"electronic","value":"1826-6983"}],"subject":[],"published":{"date-parts":[[2017,1,9]]}}}